Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	1551.13	1025.76	62.12
Graham Fair Price	48.89	2.80	1.88
PEG	-98.91	0.06	5.77
Price/Book	-6.59	2.87	3.08
Price/Cash Flow	-18.96	124.36	153.46
Prices/Earnings	-60.65	-20.60	52.35
Price/Sales	-6.40	8.24	8.80
Price/FCF	-18.96	124.36	153.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-4.65	0.55	0.58
Operating Margin	-42.73	-0.05	0.09
ROA	144.70	-0.01	< 0.005
ROE	0.01	-0.03	137.37
ROIC	< 0.005	-0.01	67.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.12	0.08	61.16
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.40	-1.55	288.39
EPS QOQ	0.09	-3.29	3523.81
FCF QOQ	-0.67	0.12	-82.49
Revenue QOQ	0.03	-0.03	25.45
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	97.27	84.91	-12.71
Days Sales Outstanding (DSO)	85.19	89.49	5.04
Inventory Turnover	0.93	1.06	14.56
Debt/Capitalization	0.52	0.48	-7.80
Quick Ratio	2.59	3.21	23.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3.27	3.16	-3.36
Cash	2.56	2.18	-14.72
Capex	-0.03	-0.01	44.95
Free Cash Flow	0.07	0.07	11.39
Revenue	1.14	1.10	-3.56
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	3.09	3.81	23.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.97	104.36	1648.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating